A sleep apnea machine is today’s more effective treatment solution for obstructive sleep apnea. If you are a sleep apnea patient and have just lately been using a sleep apnea machine, you might need to know if you are executing the treatment methods appropriately. Sleep apnea therapy that is appropriately done could make the treatment method do the job almost 100% in order to avoid apnea episodes.

First, check if you are getting the correct quantity of pressure prescribed. Additionally, just be sure you are using the sleep apnea machine as often as recommended, which in most of the cases, it must be used every night. Compliance to the particular prescribed therapy is very important to acquire good benefits. The machine quite possibly cost you thousands of dollars so you might as well put it to use and use it right. Typically, you can get the insurance to cover the cost of the machines or perhaps greater part of the cost of it. Read the rest of this entry

SleepApneaDisorder/[Press Release]/MINNEAPOLIS, Jan. 19, 2011 /Nonin Medical, Inc., the inventor of fingertip pulse oximetry and an innovator of noninvasive physiological monitoring solutions, today announced the United States and Canadian launches of its WristOx2™, Model 3150 wrist-worn pulse oximeter.

The WristOx2, Model 3150 is a compact, wireless wrist-worn monitoring device that accurately monitors blood-oxygen saturation (SpO2) levels and pulse rate in patients undergoing ambulatory monitoring to screen for breathing disorders such as chronic obstructive pulmonary disease or sleep disorders such as obstructive sleep apnea. Engineered with Nonin’s PureSAT® SpO2 technology, the WristOx2, Model 3150 is proven clinically accurate in the widest range of clinical settings and challenging patient conditions such as motion and low perfusion. Featuring Bluetooth® wireless technology, a new ergonomic design and larger screen size, the WristOx2, Model 3150 is designed to increase patient comfort and ease of use. Read the rest of this entry

GlobalData’s medical equipment report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2016” provides key market data on the Israel anesthesia and respiratory devices market.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems. Read the rest of this entry

Research and Markets has announced the addition of GlobalData’s new report “North America Anesthesia and Respiratory Devices Market Outlook to 2016″.

This new report provides key market data on the North America Anesthesia and Respiratory Devices market United States and Canada. The report provides value (USD million) data for all the market categories Airway Anesthesia Disposables, Anesthesia Machines, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices, Sleep Apnea Diagnostic Systems, Regional Anesthesia Disposables, and Pain Management Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Research and Markets has announced the addition of GlobalData’s new report “Europe Anesthesia and Respiratory Devices Market Outlook to 2016″ to their offering.

“Europe Anesthesia and Respiratory Devices Market Outlook to 2016″ provides key market data on the Europe Anesthesia and Respiratory Devices market United Kingdom, Germany, France, Italy and Spain. The report provides value (US$ million) data for all the market categories Airway Anesthesia Disposables, Anesthesia Machines, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices, Sleep Apnea Diagnostic Systems, Regional Anesthesia Disposables, and Pain Management Devices.

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants and is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Globaldata’s team of industry experts.

Research and Markets has announced the addition of the “Korea Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015″ report to their offering

This report provides critical market data on the patient monitoring and diagnostics sector in Korea. It includes key market categories such as wireless hospital ambulatory monitors, multiparameter patient monitors, remote monitoring systems, blood pressure monitors, micro-electromechanical systems, cardiovascular monitoring systems, sleep apnea diagnostic systems, hearing diagnostics and glucose monitoring devices.

The report also provides market size of products in value ($mn), & volume (units) at each level of segmentation, average selling price ($) for each product type (last level of segmentation), and market shares (%) of companies at sector and category level.

Research and Markets has announced the addition of the “Argentina Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015″ report to their offering.

This report provides critical market data on the patient monitoring and diagnostics sector in Argentina. It includes key market categories- such as wireless hospital ambulatory monitors, multiparameter patient monitors, remote monitoring systems, blood pressure monitors, micro-electromechanical systems, cardiovascular monitoring systems, sleep apnea diagnostic systems, hearing diagnostics and glucose monitoring devices.

The report also provides market size of products in value ($mn), & volume (units) at each level of segmentation-, average selling price ($) for each product type (last level of segmentation), and market shares (%) of companies at sector and category level.

PulseOximetersDIRECT.com introduces the first Pediatric Pulse Oximeter from Landon Medical. The Landon Medical LM-500 Pediatric Oximeter is specifically manufactured for children vital sign monitoring. Landon Medical’s LM-500 (FDA Approved) Pediatric Pulse Oximeter provides on spot SpO2 (percentage of oxygen saturation in the blood) and pulse rate of children with accuracy and ease. The LM-500 offers a special design and chipset technology specifically manufactured for a kid’s finger. It uses a customized pediatric oximetry sensor adusted for children’s skin to ensure accurate readings.

The LM-500 Pediatric Oximeter is widely-used in all healthcare facilities, including hospitals, nursing homes, outpatient surgery centers, physician offices, dental clinics, emergency and ambulatory situations, as well as for home diagnostics to monitor such illnesses as cardiac issues, respiratory problems, asthma, and many more. The LM-500 Oximeter model features the latest Organic Light Emitting Device (OLED) color display and Plethysmograph capabilities.

SleepApneaDisorder/[ Press Reease ]/ The US leads the global sleep apnea market and accounts for a major share of the global market. Favorable reimbursement changes and development in Home Sleep Testing are likely to provide further impetus to the market in the US. The region’s sleep apnea market continues to grow at a steady pace, despite the economic bottlenecks that adversely affected the performance of healthcare market in recent years. Therapeutic Devices dominate the overall sleep apnea market. By the year 2015, CPAP Devices market in the US is projected to cross US$1.0 billion. In Europe, around 20 million people are affected by long-term, chronic sleep disorders. In addition, around 10 million people experience intermittent sleeping trouble. Growth in patient population in Europe is supported by the increasing cases of obesity and ageing population. European market for Sleep Apnea Diagnostic Devices is projected to reach US$114 million by 2013. Read the rest of this entry

According to a new report by iData Research , the leading global authority in medical device and pharmaceutical market research, the U.S. patient monitoring market is expected to reach almost $4 billion by 2017. Multi-parameter vital-sign devices represented the majority of the patient monitoring market in 2010, with the home telehealth segment growing over 17% in 2010 and the hospital wireless telemetry monitoring segment growing at high double-digit rates. The second largest segment of this market was pulse oximetry, which is expected to exceed $934 million by 2017. Read the rest of this entry

As Americans get heavier and heavier, the incidence of obstructive sleep apnea increases, and results from two clinical studies presented at ANESTHESIOLOGY 2010 reinforce the need for physicians to screen for the disorder prior to surgery in order to appropriately manage the patient in the operating room.

“If patients with unidentified obstructive sleep apnea undergo surgery, they may have an increased chance of experiencing complications during and after surgery,” said Frances Chung, F.R.C.P.C., investigator on both studies and Professor, Department of Anesthesia, University Health Network, University of Toronto. “A growing amount of evidence suggests that obstructive sleep apnea is associated with heart and lung disease, diabetes mellitus and a higher rate of early death.” Read the rest of this entry

In a recently concluded research the researchers aimed to estimate the population prevalence of obstructive sleep apnoea (OSA) in an urban community of German third graders (age range 7.3–12.4 yrs) and the diagnostic test accuracy of two OSA screening methods.

Using a cross-sectional study design with a multi-stage sampling strategy, 27 out of 59 primary schools within the city limits of Hanover, Germany, were selected. 1,144 third graders were screened for symptoms and signs of OSA using questionnaires and nocturnal home pulse oximetry. 183 children underwent abbreviated nocturnal home polysomnography (OSA definition: apnoea/hypopnoea index ?1) and 22 were diagnosed to suffer from OSA. Read the rest of this entry

Landon Medical, the leading manufacturer of Pulse Oximeters revolutionizes the oximeter industry with the first affordable, FDA-approved Landon Medical LM-800 Fingertip Pulse Oximeter priced at $39.

The LM-800 Fingertip Pulse Oximeter measures SpO2 (percentage of oxygen saturation in the blood) and pulse rate with accuracy and ease. Specifically manufactured to be lightweight and portable the LM-800 model provides fast and accurate readings of blood oxygen saturation and pulse rate. Small and compact, it provides complete oximetry solutions while still able to fit in your pocket.

“It is without a doubt that affordability of a pulse oximeter is one of the largest barriers to patients purchasing this incredible medical device,” said Dr. Shiv Khanna of the Lavale Clinic based in Cumberland, MD. “However, an oximeter priced at $39 is truly a step in the right direction as far as allowing those who couldn’t typically afford a pulse oximeter access to this essential medical device.”

The LM-800 Pulse Oximeter is a widely-used medical device all healthcare facilities, including hospitals, nursing homes, outpatient surgery centers, physician offices, dentist offices, emergency and ambulatory situations, sport athletes, as well for home diagnostics for monitoring such illnesses as sleep apnea,COPD, cardiac problems, respiratory issues, asthma, and many more.